Trademark: 90238290
Status Date
Friday, October 27, 2023
Filing Date
Tuesday, October 6, 2020
Published for Opposition
Tuesday, April 6, 2021
5 Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans, namely, for the treatment of neuroinflammatory and neurodegenerative diseases and disorders, and for neuroprotection
Oct 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 27, 2023
Sou Extension 5 Granted
Oct 19, 2023
Sou Extension 5 Filed
Oct 27, 2023
Case Assigned To Intent To Use Paralegal
Oct 19, 2023
Sou Teas Extension Received
Apr 17, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 17, 2023
Teas Change Of Correspondence Received
Apr 17, 2023
Teas Change Of Owner Address Received
Apr 7, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 5, 2023
Sou Extension 4 Granted
Apr 5, 2023
Sou Extension 4 Filed
Apr 5, 2023
Sou Teas Extension Received
Nov 24, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 22, 2022
Sou Extension 3 Granted
Nov 22, 2022
Sou Extension 3 Filed
Nov 22, 2022
Sou Teas Extension Received
May 24, 2022
Notice Of Approval Of Extension Request E-Mailed
May 20, 2022
Sou Extension 2 Granted
May 20, 2022
Sou Extension 2 Filed
May 20, 2022
Sou Teas Extension Received
Dec 1, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 29, 2021
Sou Extension 1 Granted
Nov 29, 2021
Sou Extension 1 Filed
Nov 29, 2021
Sou Teas Extension Received
Jun 1, 2021
Noa E-Mailed - Sou Required From Applicant
Apr 6, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 6, 2021
Published For Opposition
Mar 17, 2021
Notification Of Notice Of Publication E-Mailed
Feb 27, 2021
Approved For Pub - Principal Register
Feb 27, 2021
Assigned To Examiner
Nov 19, 2020
New Application Office Supplied Data Entered
Oct 9, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24